US Stock MarketDetailed Quotes

NKPH NIKA PHARMACEUTICALS INC

Watchlist
  • 0.700
  • 0.0000.00%
15min DelayClose Apr 24 16:00 ET
756.21MMarket Cap0.00P/E (TTM)

NIKA PHARMACEUTICALS INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-92.30%-64.83K
-516.54%-27.81K
-209.85%-19.57K
-129.17%-33.72K
-356.06%-15.05K
-190.44%-7.84K
-52.42%-4.51K
-9.77%-6.32K
-65.17%-14.71K
42.58%-3.3K
Net income from continuing operations
97.96%-64.83K
99.12%-27.81K
-209.85%-19.57K
-21,540.26%-3.18M
-356.06%-15.05K
-134.86%-6.34K
-106,557.99%-3.16M
-9.77%-6.32K
-65.17%-14.71K
62.27%-3.3K
Other non cash items
----
----
----
--3.15M
--0
--0
----
----
----
----
Change In working capital
----
--0
--0
----
----
---1.5K
--1.5K
--0
--0
--0
-Change in payables and accrued expense
----
--0
--0
----
----
---1.5K
--1.5K
--0
----
----
Cash from discontinued investing activities
Operating cash flow
-92.30%-64.83K
-516.54%-27.81K
-209.85%-19.57K
-129.17%-33.72K
-356.06%-15.05K
-190.44%-7.84K
-52.42%-4.51K
-9.77%-6.32K
-65.17%-14.71K
42.58%-3.3K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
144.49%83.57K
165.19%34.4K
286.08%23.17K
153.19%34.18K
500.00%12K
-19.80%3.21K
548.60%12.97K
9.09%6K
28.35%13.5K
-72.82%2K
Net issuance payments of debt
245.60%83.57K
1,057.47%34.4K
286.08%23.17K
79.11%24.18K
500.00%12K
-19.80%3.21K
48.60%2.97K
9.09%6K
28.35%13.5K
-72.82%2K
Net common stock issuance
--0
----
----
--10K
--0
--0
----
----
--0
--0
Cash from discontinued financing activities
Financing cash flow
144.49%83.57K
165.19%34.4K
286.08%23.17K
153.19%34.18K
500.00%12K
-19.80%3.21K
548.60%12.97K
9.09%6K
28.35%13.5K
-72.82%2K
Net cash flow
Beginning cash position
116.54%864
5,272.29%4.46K
116.54%864
-75.23%399
130.37%3.91K
2,046.98%8.55K
-93.88%83
-75.23%399
--1.61K
--1.7K
Current changes in cash
3,928.39%18.73K
-22.08%6.59K
1,237.66%3.6K
138.37%465
-134.62%-3.05K
-455.96%-4.63K
982.38%8.46K
-24.41%-316
-175.23%-1.21K
---1.3K
End cash Position
2,168.06%19.6K
29.35%11.05K
5,272.29%4.46K
116.54%864
116.54%864
130.37%3.91K
2,046.98%8.55K
-93.88%83
-75.23%399
-75.23%399
Free cash flow
-92.30%-64.83K
-516.54%-27.81K
-209.85%-19.57K
-129.17%-33.72K
-356.06%-15.05K
-190.44%-7.84K
-52.42%-4.51K
-9.77%-6.32K
-65.17%-14.71K
42.58%-3.3K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -92.30%-64.83K-516.54%-27.81K-209.85%-19.57K-129.17%-33.72K-356.06%-15.05K-190.44%-7.84K-52.42%-4.51K-9.77%-6.32K-65.17%-14.71K42.58%-3.3K
Net income from continuing operations 97.96%-64.83K99.12%-27.81K-209.85%-19.57K-21,540.26%-3.18M-356.06%-15.05K-134.86%-6.34K-106,557.99%-3.16M-9.77%-6.32K-65.17%-14.71K62.27%-3.3K
Other non cash items --------------3.15M--0--0----------------
Change In working capital ------0--0-----------1.5K--1.5K--0--0--0
-Change in payables and accrued expense ------0--0-----------1.5K--1.5K--0--------
Cash from discontinued investing activities
Operating cash flow -92.30%-64.83K-516.54%-27.81K-209.85%-19.57K-129.17%-33.72K-356.06%-15.05K-190.44%-7.84K-52.42%-4.51K-9.77%-6.32K-65.17%-14.71K42.58%-3.3K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 144.49%83.57K165.19%34.4K286.08%23.17K153.19%34.18K500.00%12K-19.80%3.21K548.60%12.97K9.09%6K28.35%13.5K-72.82%2K
Net issuance payments of debt 245.60%83.57K1,057.47%34.4K286.08%23.17K79.11%24.18K500.00%12K-19.80%3.21K48.60%2.97K9.09%6K28.35%13.5K-72.82%2K
Net common stock issuance --0----------10K--0--0----------0--0
Cash from discontinued financing activities
Financing cash flow 144.49%83.57K165.19%34.4K286.08%23.17K153.19%34.18K500.00%12K-19.80%3.21K548.60%12.97K9.09%6K28.35%13.5K-72.82%2K
Net cash flow
Beginning cash position 116.54%8645,272.29%4.46K116.54%864-75.23%399130.37%3.91K2,046.98%8.55K-93.88%83-75.23%399--1.61K--1.7K
Current changes in cash 3,928.39%18.73K-22.08%6.59K1,237.66%3.6K138.37%465-134.62%-3.05K-455.96%-4.63K982.38%8.46K-24.41%-316-175.23%-1.21K---1.3K
End cash Position 2,168.06%19.6K29.35%11.05K5,272.29%4.46K116.54%864116.54%864130.37%3.91K2,046.98%8.55K-93.88%83-75.23%399-75.23%399
Free cash flow -92.30%-64.83K-516.54%-27.81K-209.85%-19.57K-129.17%-33.72K-356.06%-15.05K-190.44%-7.84K-52.42%-4.51K-9.77%-6.32K-65.17%-14.71K42.58%-3.3K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.